GLP-1s for Weight Loss

ACOSTA GROUP'S recent proprietary GLP-1 Shopper Community study focused on consumers using the medications specifically to support weight loss.

Among several new insights for brands and retailers, the study reflects that consumers are taking these medications for relatively short periods of time. Most individuals currently taking a GLP-1 for weight loss plan to continue for less than two more years, and 90% of those who had discontinued use were on the medication for less than one year.  

“Consumers' overall high satisfaction with these medications for weight loss has been tempered primarily by concerns about side effects, weight gain if discontinued, and cost,” said Kathy Risch, SVP, Shopper Insights and Thought Leadership, Acosta Group.

“It was particularly interesting to learn what lasting impacts a GLP-1 medication may have on consumers – they continue to try to maintain those healthy eating habits even as the ‘food noise’ returns.”